Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Mauss · SciRah

Researcher profile · Semantic Scholar

S. Mauss

Share profile

S. Mauss — researcher profile on SciRah

h-index: 51
Works: 396
Citations: 13K

Most-cited papers

Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.
S. Blach, S. Zeuzem, M. Manns, I. Altraif +218 more
2017The Lancet Gastroenterology and Hepatology1,875 citations Open access
Semantic Scholar
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.
D. Razavi-Shearer, I. Gamkrelidze, M. Nguyen, Ding-Shinn Chen +192 more
2018The Lancet Gastroenterology and Hepatology1,465 citations Open access
Semantic Scholar
Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients - FINITE study.
T. Berg, K. Simon, S. Mauss, E. Schott +14 more
2017Journal of Hepatology269 citations
Semantic Scholar
HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe.
P. Ingiliz, T. Martin, A. Rodger, H. Stellbrink +9 more
2017Journal of Hepatology193 citations Open access
Semantic Scholar
Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV‐positive persons version 9.0
L. Ryom, C. Boesecke, M. Bracchi, J. Ambrosioni +51 more
2018HIV Medicine138 citations Open access
Semantic Scholar
Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals.
J. Dietz, S. Susser, J. Vermehren, K. Peiffer +21 more
2017Gastroenterology133 citations
Semantic Scholar
Real‐world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C infection: data from the German Hepatitis C‐Registry
T. Berg, U. Naumann, A. Stoehr, C. Sick +8 more
2019Alimentary Pharmacology and Therapeutics112 citations
Semantic Scholar
Direct‐acting antiviral treatment of chronic HCV‐infected patients on opioid substitution therapy: Still a concern in clinical practice?
S. Christensen, P. Buggisch, S. Mauss, K. Böker +7 more
2018Addiction80 citations
Semantic Scholar
Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infection.
D. Wyles, O. Weiland, Betty B. Yao, F. Weilert +10 more
2018Journal of Hepatology79 citations Open access
Semantic Scholar
Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study
M. Lemoine, L. Assoumou, S. De Wit, P. Girard +19 more
2019Journal of Acquired Immune Deficiency Syndromes63 citations Open access
Semantic Scholar
Reinfection with the hepatitis C virus in men who have sex with men after successful treatment with direct-acting antivirals in Germany: Current incidence rates compared with rates during the interferon era.
P. Ingiliz, M. Wehmeyer, C. Boesecke, J. Schulze zur Wiesch +8 more
2020Clinical Infectious Diseases61 citations Open access
Semantic Scholar
High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance‐associated substitutions in hepatitis C genotype 3 infection
J. von Felden, J. Vermehren, P. Ingiliz, S. Mauss +14 more
2018Alimentary Pharmacology and Therapeutics61 citations Open access
Semantic Scholar
Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C.
P. Buggisch, J. Vermehren, S. Mauss, R. Günther +10 more
2017Journal of Hepatology56 citations
Semantic Scholar
Rates of sustained virological response 12 weeks after the scheduled end of direct‐acting antiviral (DAA)‐based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?
J. Bischoff, S. Mauss, C. Cordes, T. Lutz +7 more
2018HIV Medicine42 citations
Semantic Scholar
Treatment of HCV genotype 2 with sofosbuvir and ribavirin results in lower sustained virological response rates in real life than expected from clinical trials
F. Tacke, Rainer Günther, P. Buggisch, H. Klinker +8 more
2017Liver international (Print)41 citations
Semantic Scholar
Real-world treatment for chronic hepatitis C infection in Germany: Analyses from drug prescription data, 2010-2015.
R. Zimmermann, C. Kollan, P. Ingiliz, S. Mauss +2 more
2017Journal of Hepatology35 citations
Semantic Scholar
Lipid changes due to tenofovir alafenamide are reversible by switching back to tenofovir disoproxil fumarate.
A. Milinkovic, F. Berger, A. Arenas-Pinto, S. Mauss
2019AIDS (London)34 citations Open access
Semantic Scholar
Can HCV be eliminated among HIV-positive men who have sex with men in Berlin? A modeling analysis.
N. Martin, K. Jansen, Matthias An der Heiden, C. Boesecke +10 more
2019Journal of Infectious Diseases30 citations Open access
Semantic Scholar
Dynamics of liver stiffness by transient elastography in patients with chronic hepatitis C virus infection receiving direct‐acting antiviral therapy—Results from the German Hepatitis C‐Registry
V. Knop, S. Mauss, T. Goeser, A. Geier +29 more
2020Journal of Viral Hepatitis29 citations
Semantic Scholar
Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs
F. Tacke, K. Boeker, H. Klinker, R. Heyne +8 more
2020Liver international (Print)29 citations
Semantic Scholar
Real‐world effectiveness of sofosbuvir‐based treatment regimens for chronic hepatitis C genotype 3 infection: Results from the multicenter German hepatitis C cohort (GECCO‐03)
M. Wehmeyer, P. Ingiliz, S. Christensen, D. Hueppe +12 more
2018Journal of Medical Virology29 citations
Semantic Scholar
Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany
Daniel Schmidt, C. Kollan, B. Bartmeyer, V. Bremer +88 more
2022Infection28 citations Open access
Semantic Scholar
Treatment of hepatitis C genotype 1 infection in Germany: effectiveness and safety of antiviral treatment in a real-world setting
C. Höner zu Siederdissen, P. Buggisch, K. Böker, E. Schott +8 more
2018United European Gastroenterology journal25 citations Open access
Semantic Scholar
Liver Cirrhosis as a Risk Factor for Direct-Acting Antiviral Therapy Failure in Real-Life Hepatitis C Virus/Human Immunodeficiency Virus Coinfection
C. Boesecke, P. Ingiliz, F. Berger, T. Lutz +6 more
2017Open Forum Infectious Diseases24 citations Open access
Semantic Scholar
Screening HIV patients at risk for NAFLD using MRI-PDFF and transient elastography: a European multicenter prospective study.
M. Lemoine, L. Assoumou, P. Girard, M. Valantin +24 more
2022Clinical Gastroenterology and Hepatology22 citations
Semantic Scholar
Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure.
J. Dietz, B. Müllhaupt, P. Buggisch, Christiana Graf +18 more
2022Journal of Hepatology21 citations
Semantic Scholar
Deutsches Hepatitis C-Register (DHC-R) – eine Zwischenbilanz 4 Jahre nach Zulassung direkt antiviraler Substanzen (DAAs)
D. Hüppe, Y. Serfert, P. Buggisch, S. Mauss +12 more
2019Zeitschrift für Gastroenterologie - German Journal of Gastroenterology20 citations
Semantic Scholar
Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections.
J. Dietz, U. Spengler, B. Müllhaupt, J. Schulze zur Wiesch +303 more
2019Clinical Gastroenterology and Hepatology20 citations Open access
Semantic Scholar
Effectiveness and Safety of Direct-Acting Antiviral Combination Therapies for Treatment of Hepatitis C Virus in Elderly Patients: Results from the German Hepatitis C Registry
G. Dultz, Tobias Müller, J. Petersen, S. Mauss +10 more
2018Drugs & Aging19 citations
Semantic Scholar
Clinical significance of detectable and quantifiable HCV RNA at the end of treatment with ledipasvir/sofosbuvir in GT1 patients
B. Maasoumy, P. Buggisch, S. Mauss, K. Boeker +8 more
2018Liver international (Print)19 citations
Semantic Scholar
Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis
P. Lampertico, S. Mauss, M. Persico, S. Barclay +8 more
2020Advances in Therapy18 citations Open access
Semantic Scholar
Risk factors for mortality and clinical presentation of monkeypox
Salma Triana-González, Cristina Román-López, S. Mauss, Ana Luz Cano-Díaz +4 more
2023AIDS (London)16 citations
Semantic Scholar
Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C—Results from the German Hepatitis C-Registry (DHC-R)
B. Schlevogt, K. Boeker, S. Mauss, H. Klinker +7 more
2021Biomedicines16 citations Open access
Semantic Scholar
Obstacles to HBV functional cure: Late presentation in HIV and its impact on HBV seroconversion in HIV/HBV coinfection
K. Bremen, C. Hoffmann, S. Mauss, T. Lutz +13 more
2020Liver international (Print)16 citations Open access
Semantic Scholar
Glecaprevir/pibrentasvir is safe and effective in hepatitis C patients with cirrhosis: Real‐world data from the German Hepatitis C‐Registry
H. Wedemeyer, P. Erren, U. Naumann, A. Rieke +5 more
2021Liver international (Print)14 citations Open access
Semantic Scholar
Clinical and Patient-Reported Outcomes of Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C Among Patients on Opioid Agonist Treatment: A Real-world Prospective Cohort Study
B. Schulte, C. Schmidt, J. Manthey, L. Strada +11 more
2020Open Forum Infectious Diseases14 citations Open access
Semantic Scholar
Alcohol and Cannabis Consumption Does Not Diminish Cure Rates in a Real-World Cohort of Chronic Hepatitis C Virus Infected Patients on Opioid Substitution Therapy—Data From the German Hepatitis C-Registry (DHC-R)
S. Christensen, P. Buggisch, S. Mauss, K. Böker +7 more
2019Substance Abuse: Research and Treatment14 citations Open access
Semantic Scholar
Estimation of liver fibrosis by noncommercial serum markers in comparison with transient elastography in patients with chronic hepatitis C virus infection receiving direct‐acting antiviral treatment
V. Knop, W. Hofmann, P. Buggisch, H. Klinker +9 more
2018Journal of Viral Hepatitis13 citations
Semantic Scholar
Has Increased Rollout of Direct Acting Antiviral Therapy Decreased the Burden of Late Presentation and Advanced Liver Disease in Patients Starting Hepatitis C Virus Therapy in Germany?
J. Bischoff, C. Boesecke, P. Ingiliz, F. Berger +9 more
2020Journal of Clinical Gastroenterology12 citations
Semantic Scholar
Prognostic impact of steatosis in the clinical course of chronic HCV infection—Results from the German Hepatitis C-Registry
M. Rau, P. Buggisch, S. Mauss, K. Boeker +5 more
2022PLoS ONE11 citations Open access
Semantic Scholar
Low spontaneous clearance rates of recently acquired hepatitis C virus in HIV-positive MSM (The PROBE-C Study).
M. Monin, P. Ingiliz, T. Lutz, S. Scholten +11 more
2022Clinical Infectious Diseases10 citations
Semantic Scholar
Barriers to initiation of hepatitis C virus therapy in Germany: A retrospective, case-controlled study
P. Buggisch, H. Heiken, S. Mauss, B. Weber +9 more
2021PLoS ONE9 citations Open access
Semantic Scholar
Treatment-failure to direct antiviral HCV regimens in real world: frequency, patient characteristics and rescue therapy – data from the German hepatitis C registry (DHC-R)
A. Schmitt, R. Günther, S. Mauss, K. Boeker +11 more
2020Zeitschrift für Gastroenterologie - German Journal of Gastroenterology9 citations
Semantic Scholar
First real-world data on safety and effectiveness of glecaprevir/pibrentasvir for the treatment of patients with chronic hepatitis C virus infection: Data from the German Hepatitis C-Registry
T. Berg, U. Naumann, A. Stoehr, Christoph Sick +7 more
20189 citations
Semantic Scholar
Risk factors for HCV transmission in HIV-positive men who have sex with men in México
J. A. Mata-Marín, Armando Abraham de Pablos-Leal, S. Mauss, C. I. Arroyo-Anduiza +6 more
2022PLoS ONE8 citations Open access
Semantic Scholar
The changing characteristics of patients infected with chronic hepatitis C virus from 2014 to 2019: Real‐world data from the German Hepatitis C‐Registry (DHC‐R)
D. Hüppe, A. Stoehr, P. Buggisch, S. Mauss +6 more
2021Journal of Viral Hepatitis8 citations Open access
Semantic Scholar
Risk factors for remaining liver injury in patients with virological elimination of chronic hepatitis C
S. Mauss, L. Buendgens, S. Christensen, P. Ingiliz +7 more
2019Zeitschrift für Gastroenterologie - German Journal of Gastroenterology8 citations
Semantic Scholar
Outcomes and costs of treating hepatitis C patients with second-generation direct-acting antivirals: results from the German Hepatitis C-Registry
Kathrin Krüger, C. Krauth, S. Rossol, S. Mauss +6 more
2019European Journal of Gastroenterology and Hepathology7 citations
Semantic Scholar
Evaluation of Point Shear Wave Elastography Using Acoustic Radiation Force Impulse Imaging for Longitudinal Fibrosis Assessment in Patients with HBeAg-Negative HBV Infection
Christiana Graf, A. Mondorf, V. Knop, K. Peiffer +19 more
2019Journal of Clinical Medicine6 citations Open access
Semantic Scholar
Hepatitis C therapy with direct antiviral agents in patients with advanced chronic kidney disease: real-world experience of the German Hepatitis C-Registry (Deutsches Hepatitis C-Register).
J. Wiegand, P. Buggisch, S. Mauss, K. Boeker +9 more
2019European Journal of Gastroenterology and Hepathology6 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Buggisch×18
Invite
P. Buggisch — researcher profile on SciRah
T. Berg×15
Invite
T. Berg — researcher profile on SciRah
H. Klinker×14
Invite
H. Klinker — researcher profile on SciRah
C. Sarrazin×13
Invite
C. Sarrazin — researcher profile on SciRah

×13

Invite

K. Simon — researcher profile on SciRah

Invite

T. Lutz — researcher profile on SciRah

H. Wedemeyer×12

Invite

H. Wedemeyer — researcher profile on SciRah

Invite

P. Ingiliz — researcher profile on SciRah

Invite

S. Zeuzem — researcher profile on SciRah

C. Boesecke×11

Invite

C. Boesecke — researcher profile on SciRah

A. Baumgarten×11

Invite

A. Baumgarten — researcher profile on SciRah

Invite

D. Hüppe — researcher profile on SciRah